Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Inn Med (Heidelb) ; 65(2): 137-149, 2024 Feb.
Artículo en Alemán | MEDLINE | ID: mdl-38276977

RESUMEN

Many patients seek pretravel advice during routine consultations in a general practice so that basic knowledge of travel medicine is warranted. Using the example of trips to Bali, Peru and Tanzania, the most relevant topics of a pretravel consultation for these popular destinations are depicted. These include vaccinations, malaria prevention and recommendations on exposure prophylaxis for insect bites. Furthermore, special risk situations, such as travel to high altitudes or freshwater contact are discussed. In special cases, the advice of an expert in travel medicine is needed.


Asunto(s)
Viaje , Vacunación , Humanos , Derivación y Consulta , Perú , Indonesia
2.
J Travel Med ; 30(2)2023 04 05.
Artículo en Inglés | MEDLINE | ID: mdl-36573483

RESUMEN

Increasing numbers of travellers returning from Cuba with dengue virus infection were reported to the GeoSentinel Network from June to September 2022, reflecting an ongoing local outbreak. This report demonstrates the importance of travellers as sentinels of arboviral outbreaks and highlights the need for early identification of travel-related dengue.


Asunto(s)
Dengue , Viaje , Humanos , Dengue/epidemiología , Enfermedad Relacionada con los Viajes , Cuba , Brotes de Enfermedades
3.
J Clin Microbiol ; 55(6): 1894-1901, 2017 06.
Artículo en Inglés | MEDLINE | ID: mdl-28381608

RESUMEN

Serological diagnosis of Zika virus is challenging due to high cross-reactivity of Zika virus with other flavivirus antibodies. Recently, a Zika NS1-based enzyme-linked immunosorbent assay (ELISA) was developed and shown to be highly specific for Zika antibody detection; however, sensitivity was evaluated for only a small number of confirmed Zika-infected patients. In this study, we measured the sensitivity and kinetics of Zika IgM and IgG antibodies using the Zika NS1-based ELISA in 105 samples from 63 returning travelers infected with Zika virus (proven by PCR or neutralization assay) from Israel, Czech Republic, Italy, Belgium, Germany, and Chile. Zika virus IgM was detected from 2 to 42 days post-symptom onset (PSO) with an overall sensitivity of 79% in the first month and 68% until 2 months PSO, while IgG antibodies were detected from 5 days to 3 years PSO with 79% sensitivity. Interestingly, significant differences in IgM sensitivity and IgM detection period were observed between Israeli and European/Chilean Zika-infected travelers, adding to the complexity of Zika infection diagnosis and suggesting that other diagnostic methods should be complemented to reduce false-negative results.


Asunto(s)
Anticuerpos Antivirales/sangre , Enfermedades Transmisibles Importadas/diagnóstico , Ensayo de Inmunoadsorción Enzimática/métodos , Pruebas Serológicas/métodos , Proteínas no Estructurales Virales/inmunología , Infección por el Virus Zika/diagnóstico , Adolescente , Adulto , Anciano , Formación de Anticuerpos , Niño , Preescolar , Chile , Europa (Continente) , Femenino , Humanos , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Masculino , Persona de Mediana Edad , Sensibilidad y Especificidad , Factores de Tiempo , Viaje , Adulto Joven
4.
Ann Intern Med ; 166(2): 99-108, 2017 01 17.
Artículo en Inglés | MEDLINE | ID: mdl-27893080

RESUMEN

Background: Zika virus has spread rapidly in the Americas and has been imported into many nonendemic countries by travelers. Objective: To describe clinical manifestations and epidemiology of Zika virus disease in travelers exposed in the Americas. Design: Descriptive, using GeoSentinel records. Setting: 63 travel and tropical medicine clinics in 30 countries. Patients: Ill returned travelers with a confirmed, probable, or clinically suspected diagnosis of Zika virus disease seen between January 2013 and 29 February 2016. Measurements: Frequencies of demographic, trip, and clinical characteristics and complications. Results: Starting in May 2015, 93 cases of Zika virus disease were reported. Common symptoms included exanthema (88%), fever (76%), and arthralgia (72%). Fifty-nine percent of patients were exposed in South America; 71% were diagnosed in Europe. Case status was established most commonly by polymerase chain reaction (PCR) testing of blood and less often by PCR testing of other body fluids or serology and plaque-reduction neutralization testing. Two patients developed Guillain-Barré syndrome, and 3 of 4 pregnancies had adverse outcomes (microcephaly, major fetal neurologic abnormalities, and intrauterine fetal death). Limitation: Surveillance data collected by specialized clinics may not be representative of all ill returned travelers, and denominator data are unavailable. Conclusion: These surveillance data help characterize the clinical manifestations and adverse outcomes of Zika virus disease among travelers infected in the Americas and show a need for global standardization of diagnostic testing. The serious fetal complications observed in this study highlight the importance of travel advisories and prevention measures for pregnant women and their partners. Travelers are sentinels for global Zika virus circulation and may facilitate further transmission. Primary Funding Source: Centers for Disease Control and Prevention, International Society of Travel Medicine, and Public Health Agency of Canada.


Asunto(s)
Vigilancia de Guardia , Viaje , Infección por el Virus Zika/epidemiología , Adolescente , Adulto , Anciano , Región del Caribe/epidemiología , América Central/epidemiología , Niño , Preescolar , Femenino , Síndrome de Guillain-Barré/epidemiología , Síndrome de Guillain-Barré/virología , Humanos , Masculino , Persona de Mediana Edad , Embarazo , Complicaciones Infecciosas del Embarazo/epidemiología , Complicaciones Infecciosas del Embarazo/virología , América del Sur/epidemiología , Adulto Joven , Infección por el Virus Zika/complicaciones
5.
Euro Surveill ; 21(27)2016 Jul 07.
Artículo en Inglés | MEDLINE | ID: mdl-27416907

RESUMEN

We evaluated EuroTravNet (a GeoSentinel subnetwork) data from June 2013 to May 2016 on 508 ill travellers returning from Brazil, to inform a risk analysis for Europeans visiting the 2016 Olympic and Paralympic Games in Brazil. Few dengue fever cases (n = 3) and no cases of chikungunya were documented during the 2013-15 Brazilian winter months, August and September, the period when the Games will be held. The main diagnoses were dermatological (37%), gastrointestinal (30%), febrile systemic illness (29%) and respiratory (11%).


Asunto(s)
Fiebre Chikungunya/epidemiología , Dengue/epidemiología , Enfermedades Gastrointestinales/epidemiología , Trastornos Respiratorios/epidemiología , Enfermedades de la Piel/epidemiología , Viaje/estadística & datos numéricos , Adolescente , Adulto , Anciano , Brasil/epidemiología , Fiebre Chikungunya/diagnóstico , Niño , Preescolar , Comorbilidad , Dengue/diagnóstico , Europa (Continente)/epidemiología , Femenino , Juegos Recreacionales , Enfermedades Gastrointestinales/diagnóstico , Humanos , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Vigilancia de la Población/métodos , Prevalencia , Trastornos Respiratorios/diagnóstico , Factores de Riesgo , Estaciones del Año , Enfermedades de la Piel/diagnóstico , Deportes/estadística & datos numéricos , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA